BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29510240)

  • 1. Expanding the phenotypic spectrum associated with OPHN1 mutations: Report of 17 individuals with intellectual disability but no cerebellar hypoplasia.
    Moortgat S; Lederer D; Deprez M; Buzatu M; Clapuyt P; Boulanger S; Benoit V; Mary S; Guichet A; Ziegler A; Colin E; Bonneau D; Maystadt I
    Eur J Med Genet; 2018 Aug; 61(8):442-450. PubMed ID: 29510240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel unconventional variants expand the allelic spectrum of OPHN1 gene.
    Nuovo S; Brankovic V; Caputi C; Casella A; Nigro V; Leuzzi V; Valente EM
    Am J Med Genet A; 2021 May; 185(5):1575-1581. PubMed ID: 33638601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon 21 deletion in the OPHN1 gene in a family with syndromic X-linked intellectual disability: Case report.
    Bogliş A; Cosma AS; Tripon F; Bãnescu C
    Medicine (Baltimore); 2020 Aug; 99(33):e21632. PubMed ID: 32872024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel in-frame deletion affecting the BAR domain of OPHN1 in a family with intellectual disability and hippocampal alterations.
    Santos-Rebouças CB; Belet S; Guedes de Almeida L; Ribeiro MG; Medina-Acosta E; Bahia PR; Alves da Silva AF; Lima dos Santos F; Borges de Lacerda GC; Pimentel MM; Froyen G
    Eur J Hum Genet; 2014 May; 22(5):644-51. PubMed ID: 24105372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological features in a female fetus with OPHN1 deletion and cerebellar hypoplasia.
    Rocas D; Alix E; Michel J; Cordier MP; Labalme A; Guilbert H; Till M; Schluth-Bolard C; de Haas P; Massardier J; Portes Vd; Edery P; Touraine R; Guibaud L; Vasiljevic A; Sanlaville D
    Eur J Med Genet; 2013 May; 56(5):270-3. PubMed ID: 23416624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the oligophrenin-1 gene (OPHN1) cause X linked congenital cerebellar hypoplasia.
    Philip N; Chabrol B; Lossi AM; Cardoso C; Guerrini R; Dobyns WB; Raybaud C; Villard L
    J Med Genet; 2003 Jun; 40(6):441-6. PubMed ID: 12807966
    [No Abstract]   [Full Text] [Related]  

  • 7. ROCK/PKA Inhibition Rescues Hippocampal Hyperexcitability and GABAergic Neuron Alterations in a Oligophrenin-1 Knock-Out Mouse Model of X-Linked Intellectual Disability.
    Busti I; Allegra M; Spalletti C; Panzi C; Restani L; Billuart P; Caleo M
    J Neurosci; 2020 Mar; 40(13):2776-2788. PubMed ID: 32098904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia.
    Zanni G; Saillour Y; Nagara M; Billuart P; Castelnau L; Moraine C; Faivre L; Bertini E; Durr A; Guichet A; Rodriguez D; des Portes V; Beldjord C; Chelly J
    Neurology; 2005 Nov; 65(9):1364-9. PubMed ID: 16221952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of 16 amino acids in the BAR domain of the oligophrenin 1 protein causes mental retardation and cerebellar hypoplasia in an Italian family.
    Pirozzi F; Di Raimo FR; Zanni G; Bertini E; Billuart P; Tartaglione T; Tabolacci E; Brancaccio A; Neri G; Chiurazzi P
    Hum Mutat; 2011 Nov; 32(11):E2294-307. PubMed ID: 21796728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of the clinical phenotype associated with OPHN1 mutations based on the clinical and neuropsychological evaluation of three families.
    Chabrol B; Girard N; N'Guyen K; Gérard A; Carlier M; Villard L; Philip N
    Am J Med Genet A; 2005 Nov; 138(4):314-7. PubMed ID: 16158428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia.
    Bergmann C; Zerres K; Senderek J; Rudnik-Schoneborn S; Eggermann T; Häusler M; Mull M; Ramaekers VT
    Brain; 2003 Jul; 126(Pt 7):1537-44. PubMed ID: 12805098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous Truncating Variants in TBC1D23 Cause Pontocerebellar Hypoplasia and Alter Cortical Development.
    Ivanova EL; Mau-Them FT; Riazuddin S; Kahrizi K; Laugel V; Schaefer E; de Saint Martin A; Runge K; Iqbal Z; Spitz MA; Laura M; Drouot N; Gérard B; Deleuze JF; de Brouwer APM; Razzaq A; Dollfus H; Assir MZ; Nitchké P; Hinckelmann MV; Ropers H; Riazuddin S; Najmabadi H; van Bokhoven H; Chelly J
    Am J Hum Genet; 2017 Sep; 101(3):428-440. PubMed ID: 28823707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance.
    Al-Owain M; Kaya N; Al-Zaidan H; Al-Hashmi N; Al-Bakheet A; Al-Muhaizea M; Chedrawi A; Basran RK; Milunsky A
    Clin Genet; 2011 Apr; 79(4):363-70. PubMed ID: 20528889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing reveals a novel CWF19L1 mutation associated with intellectual disability and cerebellar atrophy.
    Evers C; Kaufmann L; Seitz A; Paramasivam N; Granzow M; Karch S; Fischer C; Hinderhofer K; Gdynia G; Elsässer M; Pinkert S; Schlesner M; Bartram CR; Moog U
    Am J Med Genet A; 2016 Jun; 170(6):1502-9. PubMed ID: 27016154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasudil treatment in adult reverses behavioural changes and brain ventricular enlargement in Oligophrenin-1 mouse model of intellectual disability.
    Meziane H; Khelfaoui M; Morello N; Hiba B; Calcagno E; Reibel-Foisset S; Selloum M; Chelly J; Humeau Y; Riet F; Zanni G; Herault Y; Bienvenu T; Giustetto M; Billuart P
    Hum Mol Genet; 2016 Jun; 25(11):2314-2323. PubMed ID: 27146843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the phenotypic spectrum associated with OPHN1 variants.
    Schwartz TS; Wojcik MH; Pelletier RC; Edward HL; Picker JD; Holm IA; Towne MC; Beggs AH; Agrawal PB
    Eur J Med Genet; 2019 Feb; 62(2):137-143. PubMed ID: 29960046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
    Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
    Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WDR73 missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in a consanguineous family.
    Jiang C; Gai N; Zou Y; Zheng Y; Ma R; Wei X; Liang D; Wu L
    Clin Chim Acta; 2017 Jan; 464():24-29. PubMed ID: 27983999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligophrenin-1 regulates number, morphology and synaptic properties of adult-born inhibitory interneurons in the olfactory bulb.
    Redolfi N; Galla L; Maset A; Murru L; Savoia E; Zamparo I; Gritti A; Billuart P; Passafaro M; Lodovichi C
    Hum Mol Genet; 2016 Dec; 25(23):5198-5211. PubMed ID: 27742778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal Excitatory Synaptic Transmission and Plasticity Are Differentially Altered during Postnatal Development by Loss of the X-Linked Intellectual Disability Protein Oligophrenin-1.
    Cresto N; Lebrun N; Dumont F; Letourneur F; Billuart P; Rouach N
    Cells; 2022 May; 11(9):. PubMed ID: 35563851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.